These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15615070)

  • 1. Research and regulation on biosafety of GMOs in China.
    Jia S; Peng Y
    Environ Biosafety Res; 2003; 2(1):57-9. PubMed ID: 15615070
    [No Abstract]   [Full Text] [Related]  

  • 2. EU plans to label and trace GMOs.
    Dorey E
    Nat Biotechnol; 2001 Sep; 19(9):795. PubMed ID: 11533623
    [No Abstract]   [Full Text] [Related]  

  • 3. Italy employs further GMO delay tactics.
    Meldolesi A
    Nat Biotechnol; 2003 Apr; 21(4):346. PubMed ID: 12665808
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in biotechnology and biosafety in Brazil.
    Mendonça-Hagler L; Souza L; Aleixo L; Oda L
    Environ Biosafety Res; 2008; 7(3):115-21. PubMed ID: 19031659
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of GMOs in China.
    Liu Y
    J Int Bioethique; 2008 Dec; 19(4):139-58, 167. PubMed ID: 19492727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recipe for disaster.
    Nat Biotechnol; 2003 May; 21(5):465. PubMed ID: 12721554
    [No Abstract]   [Full Text] [Related]  

  • 7. The Cartagena protocol and GMOs.
    Pythoud F
    Nat Biotechnol; 2004 Nov; 22(11):1347-8. PubMed ID: 15529146
    [No Abstract]   [Full Text] [Related]  

  • 8. EC prepares strategic vision for biotechnology.
    Mitchell P
    Nat Biotechnol; 2002 Feb; 20(2):107-8. PubMed ID: 11821842
    [No Abstract]   [Full Text] [Related]  

  • 9. Putting Cartagena into practice.
    Watanabe KN; Taeb M; Okusu H
    Nat Biotechnol; 2004 Oct; 22(10):1207-8. PubMed ID: 15470448
    [No Abstract]   [Full Text] [Related]  

  • 10. Why regulate and how?
    Kinderlerer J
    Environ Biosafety Res; 2003; 2(1):51-6. PubMed ID: 15615069
    [No Abstract]   [Full Text] [Related]  

  • 11. Europe sees sharp decline in GMO research.
    Mitchell P
    Nat Biotechnol; 2003 May; 21(5):468-9. PubMed ID: 12721556
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: a call for ethical regulation of genetically created organisms (GCOs) beyond GMOs.
    Lee SY
    Biotechnol J; 2010 Aug; 5(8):791. PubMed ID: 20672287
    [No Abstract]   [Full Text] [Related]  

  • 13. Decision making under the Cartagena Protocol on Biosafety.
    Jank B; Gaugitsch H
    Trends Biotechnol; 2001 May; 19(5):194-7. PubMed ID: 11301133
    [No Abstract]   [Full Text] [Related]  

  • 14. [The critical scientists' voice].
    Lewgoy F
    Hist Cienc Saude Manguinhos; 2000; 7(2):503-8. PubMed ID: 16683329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The science and politics of plant biotechnology--a personal perspective.
    Vasil IK
    Nat Biotechnol; 2003 Aug; 21(8):849-51. PubMed ID: 12894193
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plant genetic engineering in Monsanto company: from the first laboratory experiments to worldwide practical use].
    Konov AL; Velchev M; Parcel D
    Tsitol Genet; 2005; 39(3):3-12. PubMed ID: 16250241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotech's defining moments.
    Miller HI
    Trends Biotechnol; 2007 Feb; 25(2):56-9. PubMed ID: 17173993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical assessment of regulatory triggers for products of biotechnology: Product vs. process.
    McHughen A
    GM Crops Food; 2016 Oct; 7(3-4):125-158. PubMed ID: 27813691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant biotechnology. Italian scientists blast GMO restrictions.
    Frank L
    Science; 2000 Dec; 290(5499):2046. PubMed ID: 11187815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promise and perils of synthetic biology.
    Tucker JB; Zilinskas RA
    New Atlantis; 2006; 12():25-45. PubMed ID: 16832953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.